IMMX

NASDAQStock

Immix Biopharma, Inc.

$9.95-0.16 (-1.58%)

52-Week Range

$1.36

$10.40

Key Stats

Market Cap

526.9M

P/E Ratio

—

Dividend Yield

—

Beta

0.26

Volume

488.6K

Avg Volume

615.6K

Performance

+36.07%

+62.93%

+383.73%

YTD

+86.19%

+512.73%

+434.92%

+175.48%

Price Chart

ETF Exposure

IMMX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.05%	56,613	$592K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	244,935	$1.4M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	33	$266	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,204	$10K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	5	$45	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	685,695	$4.0M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,606	$28K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	310	$2K	$1.29B	0.17%

About IMMX ETF Exposure

Immix Biopharma, Inc. (IMMX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 526.9M, IMMX is a widely held institutional stock. The stock currently trades at $9.95. Investors can gain exposure to IMMX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMMX, sorted by portfolio weight.